MON-185 MALIGNANCY PREVALENCE IS LOWER IN WAITLISTED POTENTIAL KIDNEY TRANSPLANT RECIPIENTS COMPARED TO KIDNEY TRANSPLANT RECIPIENTS

The optimal renal replacement therapy is kidney transplantation because it improves quality of life, prolongs survival, and is cost-effective. Malignancy became the second leading cause of death in kidney allograft recipients. The aim of this study was to the prevalence of malignancy in patients with end-stage renal disease on the kidney transplantation waiting list and in kidney allograft recipients.